Ai Health Highway, a health-tech startup has raised $1.5 million in its Pre-Series A round funding led by Turbostart with a $1 million investment.
The funding round also saw participation from Rainmatter by Zerodha, The Chennai Angels, BITS BioCyTiH Foundation along other angel investors.
The funding will be used to solidify its presence in India, accelerate regulatory approvals internationally, and broaden its AI/ML offerings in the Cardio-Respiratory domain.
Venkat Raju, Founder and CEO of Turbostart, stated, “We are thrilled to support Ai Health Highway and its exceptional founding team, who bring together a powerful blend of medical expertise, business acumen, and technological innovation. Their work goes beyond upgrading the stethoscope – they’re reimagining screening tools to make healthcare more accessible in the modern age. Their smart stethoscope technology has the potential to bring quality screenings to underserved communities, democratizing access to early detection. We are excited to see how they will transform healthcare accessibility, creating meaningful impact in an industry where change is not just welcome, but necessary.”
Dr (Maj) Satish S Jeevannavar, Founder, AI Health Highway, said, “We are delighted to announce Turbostart as the Lead Investor for our Pre-Series A round, joined by co-investors Rainmatter by Zerodha and BITS BioCyTiH Foundation. Our existing investors, The Chennai Angels, along with other angel investors, have also participated in this round. We are thrilled to collaborate with Turbostart on this vital mission to tackle NCDs. The expertise of their seasoned professionals and Centers of Excellence will be invaluable as we navigate the complex global healthcare landscape.”
Founded in 2018, Ai Health Highway focuses on providing tech-enabled screening tools that help in the early detection of non-communicable diseases (NCDs) and improving healthcare accessibility through India’s first Ai-enabled stethoscope, AiSteth.
Ai Health Highway aims to reduce global premature deaths due to NCDs by 30% by 2030. NCDs account for over 41 million deaths annually, highlighting the need for early detection and intervention.
AiSteth, India’s first AI-enabled stethoscope, is revolutionizing cardiac care by assisting healthcare professionals and non-specialists in interpreting heart sounds to support accurate clinical decisions. Utilizing advanced AI and signal processing, AiSteth transforms traditional stethoscopes into powerful screening tools capable of detecting life-threatening cardiac disorders at an early stage.
The AI-enabled stethoscope seamlessly integrates into existing workflows, equipping primary care providers with high-quality heart sound capture, analysis, and data-sharing capabilities, thereby enhancing the accessibility and affordability of healthcare solutions.
